Post Learning Implementation Plan (PLIP)

Pre-course

• Access to the Educo Training Portal
• Submit your needs analysis and objectives for training by completing a simple online form

Action Plan

• At the end of the training you will create an action plan to help you implement and develop your new skills and knowledge

Reinforcement Session

• Delivered 3 to 4 weeks after the training
• It is a 1 hour virtual session enabling the group to reinforce the key learnings from the training and cover and subsequent questions and challenges

22, 23, 24 & 25 June 2026 | 7, 8, 9 & 10 December 2026

4-Day Live Online Training
Register at the top of the page.

Introductory Module 1

FREE to Attend | Live & Recorded

Sign up

20 May 2026 | 60 mins | 1:00 PM UK

Introduction to Portfolio Management

• Overview of portfolio management principles
• The role of governance in strategic decision-making
• Aligning portfolio strategy with organisational goals

Register For Module 1 | Free

There are limited spaces on module 1. If demand is high you may not be able to attend the live session, however you will be sent the recording. Priority is given to full registrations.

Day 1

22 June 2026 | 180 mins | 1:00 PM UK

Introduction to Portfolio Management

• Overview of portfolio management principles
• The role of governance in strategic decision-making
• Aligning portfolio strategy with organisational goals

Pipeline Health and Management

• Assessing pipeline diversity and balance
• Techniques for prioritising projects and resources
• Metrics and tools for monitoring pipeline health

Day 2

23 June 2026 | 180 mins | 1:00 PM UK

Risk Management in Portfolio Governance

• Identifying and quantifying risks at different portfolio stages
• Implementing risk mitigation strategies
• Decision-making frameworks for uncertain environments
  

Identifying and Managing Inflection Points

• Recognising key inflection points in the development lifecycle
• Strategic responses to clinical, regulatory, and market-driven inflection points
• Case studies on successful and unsuccessful management of inflection points

Day 3

24 June 2026 | 180 mins | 1:00 PM UK

Strategic Partnering and Collaborations

• Evaluating the benefits of partnerships and collaborations
• Criteria for selecting and managing external partners
• Leveraging partnerships to fill portfolio gaps and accelerate development

Leveraging Differentiation and Competitive Intelligence

• Tools in competitive intelligence monitoring and interpretation. What’s your edge?

Day 4

25 June 2026 | 180 mins | 1:00 PM UK

Enhancing External Visibility

• Strategies to effectively communicate portfolio progress to external stakeholders
• Building investor confidence through transparency and strategic messaging
• Tools for enhancing visibility in scientific, regulatory, and commercial communities

Case Studies and Best Practices

• Real-world examples of successful portfolio management
• Lessons learned from high-impact partnerships and collaborations
• Industry trends and future directions in biopharmaceutical portfolio management

Gareth is an experienced biopharmaceutical R&D professional, drug hunter and global project lead with 10+ years of leadership in project/program management, portfolio governance and scientific strategy. He has a successful record of progressing complex, multi-million-dollar drug development programs through internal and external initiatives. He has furthered his practical experience in both Europe and the US, in clinical, pharmaceutical, VC and academic environments facilitating the preclinical -> clinical transition of novel medicinal products. Relevant former roles and institutions include Principal Investigator/Lecturer (Harvard Medical School & Boston Children’s Hospital), Fellow and Project Lead (Vertex Pharmaceuticals), Global Project Lead (Boehringer-Ingelheim) and Asset and Scientific Evolution Lead (invoX Pharma).

In his current role(s), he leads a dynamic cross-functional global team that pushes scientific and drug development boundaries, developing novel medicinal products and drug-device combinations (modality and indication agnostic), to meet unmet patient needs worldwide. He has a wealth of experience in establishing agile governance frameworks to oversee a diverse clinical and preclinical portfolio. Notably, he has extensive experience in translational biomarker strategies, indication expansions (repurposing), and effective tech-transfer for up-scale bioprocessing of biologics.

Overseeing a global team, Gareth has a proven track record in increasing pipeline visibility and executing external collaborations. He has bridged the gap between preclinical -> clinical, implementing novel ‘first-4-patient’ initiatives, such as 5’R research frameworks, relevant clinical biomarker strategies and optimising human dose prediction models to enhance the probability of success of medicinal products.